STAT4 gene influences genetic predisposition to ulcerative colitis but not Crohn's disease in the Spanish population: A replication study

Human Immunology

Volumn 71, Issue 5, 2010, Pages 515-519

  Diaz Gallo, Lina Marcela ^a   Palomino Morales, Rogelio J ^a   Gómez García, María ^b   Cardeña, Carlos ^c   Rodrigo, Luis ^d   Nieto, Antonio ^e   Alcain, Guillermo ^f   Cueto, Ignacio ^f   López Nevot, Miguel A ^b   Martin, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Crohn's disease; Genetic association study; Inflammatory bowel disease; Signal transducer and activator of transcription 4 (STAT4) gene; Ulcerative colitis

Indexed keywords

STAT4 PROTEIN;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN VARIANT; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN; STAT4 TRANSCRIPTION FACTOR;

EID: 77951937195     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.02.005     Document Type: Article

References (44)

1. Baumgart D.C., Carding S.R. Inflammatory bowel disease: Cause and immunobiology. Lancet 2007, 369:1627.
2. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521.
3. Budarf M.L., Labbe C., David G., Rioux J.D. GWA studies: Rewriting the story of IBD. Trends Genet 2009, 25:137.
4. Danese S., Scaldaferri F., Papa A., Pola R., Sans M., Gasbarrini G., et al. Platelets: New players in the mucosal scenario of inflammatory bowel disease. Eur Rev Med Pharmacol Sci 2004, 8:193.
5. Silverberg M.S., Cho J.H., Rioux J.D., McGovern D.P., Wu J., Annese V., et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009, 41:216.
6. Marquez A., Varade J., Robledo G., Martinez A., Mendoza J.L., Taxonera C., et al. Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients. Eur J Hum Genet 2009.
7. Oliver J., Rueda B., Lopez-Nevot M.A., Gomez-Garcia M., Martin J. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:977.
8. Oliver J., Marquez A., Gomez-Garcia M., Martinez A., Mendoza J.L., Vilchez J.R., et al. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut 2007, 56:150.
9. Palomino-Morales R.J., Oliver J., Gomez-Garcia M., Lopez-Nevot M.A., Rodrigo L., Nieto A., et al. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: A meta-analysis approach. Genes Immun 2009, 10:356.
10. Barmada M.M., Brant S.R., Nicolae D.L., Achkar J.P., Panhuysen C.I., Bayless T.M., et al. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm Bowel Dis 2004, 10:513.
11. Wang K., Zhang H., Kugathasan S., Annese V., Bradfield J.P., Russell R.K., et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn disease. Am J Hum Genet 2009, 84:399.
12. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955.
13. Kaplan M.H. STAT4: A critical regulator of inflammation in vivo. Immunol Res 2005, 31:231.
14. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139.
15. Bettelli E., Korn T., Kuchroo V.K. Th17: The third member of the effector T cell trilogy. Curr Opin Immunol 2007, 19:652.
16. h cells. J Immunol 2007, 178:4901.
17. Mudter J., Weigmann B., Bartsch B., Kiesslich R., Strand D., Galle P.R., et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol 2005, 100:64.
18. Pang Y.H., Zheng C.Q., Yang X.Z., Zhang W.J. Increased expression and activation of IL-12-induced Stat4 signaling in the mucosa of ulcerative colitis patients. Cell Immunol 2007, 248:115.
19. Korman B.D., Kastner D.L., Gregersen P.K., Remmers E.F. STAT4: Genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 2008, 8:398.
20. Gregersen P.K., Olsson L.M. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 2009, 27:363.
21. Zhernakova A., van Diemen C.C., Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009, 10:43.
22. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977.
23. Orozco G., Alizadeh B.Z., Delgado-Vega A.M., Gonzalez-Gay M.A., Balsa A., Pascual-Salcedo D., et al. Association of STAT4 with rheumatoid arthritis: A replication study in three European populations. Arthritis Rheum 2008, 58:1974.
24. Abelson A.K., Delgado-Vega A.M., Kozyrev S.V., Sanchez E., Velazquez-Cruz R., Eriksson N., et al. STAT4 associates with SLE through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis 2008, 68(11):1746.
25. Palomino-Morales R.J., Rojas-Villarraga A., Gonzalez C.I., Ramirez G., Anaya J.M., Martin J. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun 2008, 9:379.
26. Sigurdsson S., Nordmark G., Garnier S., Grundberg E., Kwan T., Nilsson O., et al. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum Mol Genet 2008, 17:2868.
27. Zervou M.I., Mamoulakis D., Panierakis C., Boumpas D.T., Goulielmos G.N. STAT4: A risk factor for type 1 diabetes?. Hum Immunol 2008, 69:647.
28. Korman B.D., Alba M.I., Le J.M., Alevizos I., Smith J.A., Nikolov N.P., et al. Variant form of STAT4 is associated with primary Sjogren's syndrome. Genes Immun 2008, 9:267.
29. Rueda B., Broen J., Simeon C., Hesselstrand R., Diaz B., Suarez H., et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet 2009, 18:2071.
30. Martinez A., Varade J., Marquez A., Cenit M.C., Espino L., Perdigones N., et al. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum 2008, 58:2598.
31. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl A):5.
32. Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut 2006, 55:749.
33. Huedo-Medina T.B., Sanchez-Meca J., Marin-Martinez F., Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?. Psychol Methods 2006, 11:193.
34. Gavaghan D.J., Moore R.A., McQuay H.J. An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data. Pain 2000, 85:415.
35. Attia J., Ioannidis J.P., Thakkinstian A., McEvoy M., Scott R.J., Minelli C., et al. How to use an article about genetic association: B: Are the results of the study valid?. J Am Med Assoc 2009, 301:191.
36. Zintzaras E., Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 2008, 61:634.
37. Anaya J.M., Gomez L., Castiblanco J. Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol 2006, 13:185.
38. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661. Wellcome Trust Case Control Consortium.
39. Nunez C., Oliver J., Mendoza J.L., Gomez-Garcia M., Pinero A., Taxonera C., et al. MYO9B polymorphisms in patients with inflammatory bowel disease. Gut 2007, 56:1321.
40. + T cells that respond to bacterial antigens. J Immunol 1999, 162:1884.
41. h1 cytokine production and the severity of inflammatory bowel disease. J Immunol 2008, 181:5062.
42. Abraham C., Cho J.H. IL-23 and autoimmunity: New insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med 2009, 60:97.
43. h1, Th17 or both? The change of a paradigm: New immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009, 58:1152.
44. Parrello T., Monteleone G., Cucchiara S., Monteleone I., Sebkova L., Doldo P., et al. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J Immunol 2000, 165:7234.